4/A//SEC Filing
Schwaneke Jeffrey A. 4/A
Accession 0001628280-25-016684
CIK 0001831097other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 7:40 PM ET
Size
9.8 KB
Accession
0001628280-25-016684
Insider Transaction Report
Form 4/AAmended
Schwaneke Jeffrey A.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2023-11-29$11.22/sh+22,300$250,206→ 22,300 total(indirect: By Trust) - Award
Common Stock
2025-04-01+428,922→ 1,130,552 total - Award
Options (Right to buy)
2025-04-01+673,077→ 673,077 totalExercise: $4.08Exp: 2035-04-01→ Common Stock (673,077 underlying)
Footnotes (6)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $11.12 to $11.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
- [F2]This transaction was originally reported in November 2023 and is hereby amended to clarify that the shares were purchased by and are held in the Schwaneke Family Joint Spousal Trust.
- [F3]Restricted stock units that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment.
- [F4]Includes Performance Stock Units which may become vested subject to attainment (based on 40 trading day average closing price, exceeding twice the closing price of the Company's stock price on date of grant) and within three years from grant date.
- [F5]Includes restricted stock units.
- [F6]Options that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment.
Documents
Issuer
agilon health, inc.
CIK 0001831097
Entity typeother
Related Parties
1- filerCIK 0001446919
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 7:40 PM ET
- Size
- 9.8 KB